Join
Live feed
·
INSIDERFilingvia Quantisnow
Evelo Biosciences Inc. logo

Gill Simba sold $57 worth of shares (172 units at $0.33) and converted options into 1,172 shares, increasing direct ownership by 6% to 17,758 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
EVLO· Evelo Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EVLO (Evelo Biosciences Inc.) and more on Quantisnow.

Gill Simba sold $57 worth of shares (172 units at $0.33) and converted options into 1,172 shares, increasing direct ownership by 6% to 17,758 units (SEC Form 4) | Quantisnow